MMP9 and prostate neoplasm: In addition, the mRNA expression levels of MMP9 in the mouse prostate tumor (20, 24, and 30 weeks of age) were significantly lower in FABP4−/− TRAMP-HF than in TRAMP-HF mice (Figure 4E).